Loading company…
Akita, Japan biotechnology company developing vaccines against infectious diseases, listed on the TSE Mothers market in 2012.
Founded in 2004 and headquartered in Akita-shi, Japan, UMN Pharma develops and produces biotechnology products, mainly vaccines. It listed on the Tokyo Stock Exchange Mothers market in December 2012, with an IPO that raised JPY 4446.000 mn. The company has completed 8 deals, and for fiscal 2018 it reported revenues of JPY 932,490 mn and an EBITDA loss of JPY 5,460,930.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in